July 1, 2024
TOPLINE: People with obesity who exercise while taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs; liraglutide) showed increased weight loss and preserved bone health, according to […]
July 1, 2024
A tool routinely used to evaluate concussion in college athletes fails to accurately diagnose the condition in many cases, a new study showed. Investigators found that […]
July 1, 2024
TOPLINE: More time spent exposed to screens is associated with a higher risk for myopia in children and adolescents; the use of computers and televisions appears […]
July 1, 2024
In a shifting landscape in dementia risk factors, cardiovascular health (or the health of your heart and blood vessels) is now taking precedence. That’s according to […]
July 1, 2024
Over the past 30 years, chronic kidney disease has become one of the leading causes of death and years of healthy life lost in Latin America. […]
July 1, 2024
TOPLINE: A triple combination therapy (TCT) of metformin, dapagliflozin, and saxagliptin is an effective and safe treatment option for drug-naive patients with type 2 diabetes (T2D) […]
July 1, 2024
A new trial has found the thrombolytic reteplase to be superior to alteplase in patients with acute ischemic stroke presenting within 4.5 hours of symptom onset, […]
July 1, 2024
The MUC-1 vaccine tecemotide plus standard neoadjuvant systemic therapy was shown to notably improve distant relapse-free survival and overall survival rates in breast cancer patients, in […]
July 1, 2024
(Reuters) -AstraZeneca said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, sipavibart, for an […]